| scholarly article | Q13442814 |
| P50 | author | Sang Hee Lee | Q43022681 |
| P2093 | author name string | Sun-Shin Cha | |
| Jung Hun Lee | |||
| Seok Hoon Jeong | |||
| P2860 | cites work | The business of developing antibacterials | Q79423618 |
| Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
| Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion | Q27619344 | ||
| Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase | Q27639372 | ||
| Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate | Q31942619 | ||
| Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium | Q34047473 | ||
| Controversies about extended-spectrum and AmpC beta-lactamases | Q34213755 | ||
| The process of structure-based drug design | Q34266765 | ||
| Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19. | Q34352060 | ||
| Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase | Q34522266 | ||
| Experimental Prediction of the Evolution of Cefepime Resistance From the CMY-2 AmpC β-Lactamase | Q34617581 | ||
| Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins | Q35124477 | ||
| AmpC beta-lactamases: what do we need to know for the future? | Q35140531 | ||
| New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate | Q36094929 | ||
| The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! | Q36242554 | ||
| Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America | Q36382134 | ||
| Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate | Q36491987 | ||
| Anti-infective research and development--problems, challenges, and solutions | Q36689490 | ||
| Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement | Q37067902 | ||
| Acinetobacter infection | Q37114411 | ||
| AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins | Q37568397 | ||
| Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome | Q39478020 | ||
| Sequences of homologous beta-lactamases from clinical isolates of Serratia marcescens with different substrate specificities | Q39557037 | ||
| Mutational replacement of Leu-293 in the class C Enterobacter cloacae P99 beta-lactamase confers increased MIC of cefepime | Q39651911 | ||
| Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem | Q39740513 | ||
| Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate | Q40622081 | ||
| Naturally occurring extended-spectrum cephalosporinases in Escherichia coli | Q41474257 | ||
| Genetic and biochemical characterization of GES-5, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae | Q43168895 | ||
| Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. | Q44235785 | ||
| Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate. | Q45275764 | ||
| Characterization of the bifunctional aminoglycoside-modifying enzyme ANT(3'')-Ii/AAC(6')-IId from Serratia marcescens | Q46337932 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. | Q48029765 | ||
| Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. | Q54439224 | ||
| Molecular evolution of a class C beta-lactamase extending its substrate specificity | Q56903752 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | Gram-negative bacteria | Q632006 |
| P304 | page(s) | e1000221 | |
| P577 | publication date | 2009-03-27 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | New disturbing trend in antimicrobial resistance of gram-negative pathogens | |
| P478 | volume | 5 |
| Q37412605 | A novel biologic immunomodulator, HDFx, protects against lethal hemorrhage, endotoxins and traumatic injury: potential relevance to emerging diseases |
| Q35120382 | An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria |
| Q37845955 | Antibiotic adjuvants: multicomponent anti-infective strategies. |
| Q54394613 | Antimicrobial Activities of Bacteriocins E 50-52 and B 602 Against Antibiotic-Resistant Strains Involved in Nosocomial Infections. |
| Q36398687 | Crystallization and preliminary diffraction studies of GIM-1, a class B carbapenem-hydrolyzing β-lactamase. |
| Q36206767 | Crystallization and preliminary diffraction studies of SFC-1, a carbapenemase conferring antibiotic resistance |
| Q28649526 | Educational effectiveness, target, and content for prudent antibiotic use |
| Q41786410 | Efficient direct extended-spectrum β-lactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers |
| Q26744583 | Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods |
| Q37767653 | New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance |
| Q46091298 | Nomenclature of ISCRl elements capable of mobilizing antibiotic resistance genes present in complex class 1 integrons |
| Q24607946 | Strategies to minimize antibiotic resistance |
| Q28084628 | Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance |
| Q27696144 | Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii |
Search more.